MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 07.02.2026
I-Mab P/CF 2011-2026 | IMAB
P/CF Jährlich I-Mab
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.266 | -0.361 | -8.51 | 14.6 | -0.0134 | -0.0488 | -0.0478 | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.6 | -8.51 | 0.764 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M |  USA |
 |
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M |  Germany |
 |
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | - | - | $ 26.5 M | USA |
 |
Aptorum Group Limited
APM
|
-3.44 | $ 0.82 | -2.71 % | $ 4.47 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
-2.96 | $ 2.98 | - | $ 168 M | China |
 |
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M |  France |
 |
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.43 | -2.28 % | $ 8.25 B |  Australia |
 |
Applied Molecular Transport
AMTI
|
-0.236 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | Canada |
 |
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | USA |
 |
Athira Pharma
ATHA
|
-0.166 | - | - | $ 269 M | USA |
 |
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | USA |
 |
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
-2.48 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
-17.6 | $ 218.64 | -2.42 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
-0.159 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Aridis Pharmaceuticals
ARDS
|
-0.142 | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | USA |
 |
BioNTech SE
BNTX
|
70.7 | $ 109.46 | 0.49 % | $ 27.2 B | Germany |
 |
Burford Capital Limited
BUR
|
11.6 | $ 9.14 | -1.14 % | $ 1.46 B | Britain |
 |
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
-2.7 | - | 0.23 % | $ 488 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
Baudax Bio
BXRX
|
-0.028 | - | 0.59 % | $ 63 K | USA |
 |
Cabaletta Bio
CABA
|
-0.383 | $ 2.5 | -3.85 % | $ 2.92 M | USA |
 |
Calithera Biosciences
CALA
|
-14.5 | - | -10.95 % | $ 876 K | USA |
 |
Autolus Therapeutics plc
AUTL
|
-2.05 | $ 1.39 | -2.46 % | $ 355 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
6.19 | $ 14.82 | 0.37 % | $ 4.58 B | USA |
 |
AIkido Pharma
AIKI
|
-1.3 | - | 1.93 % | $ 17.4 M | USA |
 |
AVROBIO
AVRO
|
-0.891 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 4.36 | 0.46 % | $ 9.49 B |  Israel |
 |
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | Germany |
 |
Codexis
CDXS
|
-5.9 | $ 1.18 | -6.0 % | $ 86.6 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | USA |